I thought I had, when I talked about taking into account the differing R&D costs, which I think was the substance of the point made by noble Baroness and the noble Lord, Lord Hunt. We have to take into account both getting a good price and the R&D costs, and that needs to be reflected within a statutory scheme, and would clearly apply to the case in point.
Health Service Medical Supplies (Costs) Bill
Proceeding contribution from
Lord O'Shaughnessy
(Conservative)
in the House of Lords on Tuesday, 7 February 2017.
It occurred during Debate on bills on Health Service Medical Supplies (Costs) Bill.
About this proceeding contribution
Reference
778 c1656 Session
2016-17Chamber / Committee
House of Lords chamberSubjects
Librarians' tools
Timestamp
2022-05-10 14:25:19 +0100
URI
http://hansard.intranet.data.parliament.uk/Lords/2017-02-07/17020793000112
In Indexing
http://indexing.parliament.uk/Content/Edit/1?uri=http://hansard.intranet.data.parliament.uk/Lords/2017-02-07/17020793000112
In Solr
https://search.parliament.uk/claw/solr/?id=http://hansard.intranet.data.parliament.uk/Lords/2017-02-07/17020793000112